This content is machine translated Hematology and oncology The one-size-fits-all approach is history, personalized medicine is the future The pursuit of individuality was the focus of this year’s Congress of Oncology and Hematology in Switzerland. This paradigm shift is set to change patients’ lives and redefine cancer treatment.…
View Post 3 min This content is machine translated Medical oncology Mastering challenges, shaping innovations Interdisciplinary networking and personal exchange of experience are essential for international cooperation. Around 5500 participants took part in the DGHO in Basel. The largest congress for the specialist field in…
View Post 4 min This content is machine translated Immuno-oncological therapies CAR-T cell therapy for hematologic cancers Immunotherapies are now established pillars in the treatment of cancer. The principle of CAR-T cell therapy is that the body’s own T cells are programmed to destroy cancer cells through…
View Post 7 min This content is machine translated Hematology A closer look at hemato-oncological entities The latest advances in the field of hematology were the focus of this year’s annual meeting of the European Hematology Association in Madrid. Experts discussed research data on various diseases…
View Post 7 min This content is machine translated Hematologic oncology Healing potential based on innovative research approaches At the beginning of December, world-renowned doctors gathered in San Diego (USA) for the most important and comprehensive congress in hematological oncology. More than 20,000 visitors took part in the…
View Post 6 min This content is machine translated Hematology Overcoming boundaries – basic research, diagnostics and therapy The motto of the recently held Swiss Oncology & Hematology Congress (SOHC) was “Overcoming borders together”. A great deal of research has been and is being carried out to give…
View Post 3 min This content is machine translated Hematology MDS and MPN – harmless abbreviations for serious diseases The heterogeneous group of acquired clonal diseases of the hematopoietic stem cells of the bone marrow (myelodysplastic syndromes) are associated with an increased risk of acute myeloid leukemia or bone…
View Post 7 min This content is machine translated Hematology and medical oncology The world of hematology and oncology research The rapid technological developments in diagnostics and innovations in multimodal therapy in the field of hematology and medical oncology were the focus of the annual conference. While immunotherapies with monoclonal…
View Post 8 min This content is machine translated Hematology From anemia to blood cancer – the latest findings at a glance Hematology covers a broad spectrum of indications with very heterogeneous disease patterns. Accordingly, intensive research is being carried out to provide patients with effective treatment. Rarer diseases are examined just…
View Post 4 min This content is machine translated Hematology Thrombosis, thalassemia and co. Venous thrombosis occurred more than twice as often after placement of a PICC catheter than when conventional catheters were used. One study looked more closely at influencing factors in patients…
View Post 4 min This content is machine translated Multiple Myeloma (MM) Prognostic factors, the role of leptin and MGUS in focus. Multiple myeloma results from the degeneration of a single plasma cell whose clones spread throughout the bone marrow. Overall, the disease occurs very rarely. However, it is one of the…
